Physiological functions of glucocorticoids in stress and their relation to pharmacological actions.

Almost any kind of threat to homeostasis or stress will cause plasma glucocorticoid levels to rise. The increased levels have traditionally been ascribed the physiological function of enhancing the organism's resistance to stress, a role well recognized in glucocorticoid therapy. How the known physiological and pharmacological effects of glucocorticoids might accomplish this function, however, remains a mystery. A generalization that is beginning to emerge is that many of these effects may be secondary to modulation by glucocorticoids of the actions of numerous intercellular mediators, including established hormones, prostaglandins and other arachidonic acid metabolites, certain secreted neutral proteinases, lymphokines, and a variety of bioactive peptides. These mediators participate in physiological mechanisms--endocrine, renal, immune, neural, etc.--that mount a first line of defense against such challenges to homeostasis as hemorrhage, metabolic disturbances, infection, anxiety, and others. Contrary to the traditional view that glucocorticoids enhance these defense mechanisms, however, it has become increasingly clear that glucocorticoids at moderate to high levels generally suppress them. This paradox, which first emerged when glucocorticoids were discovered to be antiinflammatory agents, remains a major obstacle to a unified picture of glucocorticoid function. We propose that stress-induced increases in glucocorticoid levels protect not against the source of stress itself but rather against the body's normal reactions to stress, preventing those reactions from overshooting and themselves threatening homeostasis. This hypothesis, the seeds of which are to be found in many discussions of particular glucocorticoid effects, immediately accounts for the paradox noted above. Furthermore, it provides glucocorticoid physiology with a unified conceptual framework that can accommodate such apparently unrelated physiological and pharmacological effects as those on carbohydrate metabolism, inflammatory processes, shock, and water balance. It also leads us to suggest that some of the enzymes rapidly induced by glucocorticoids, such as glutamine synthetase, detoxify mediators released during stress-induced activation of primary defense mechanisms. These mediators would themselves lead to tissue damage if left unchecked.

[1]  N. Holbrook,et al.  Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocorticoids and its modulation by interferon. , 1983, Cancer research.

[2]  J. Aldenhoff,et al.  Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. , 1983, Science.

[3]  E. Sorkin,et al.  The immune response evokes changes in brain noradrenergic neurons. , 1983, Science.

[4]  R. Miller,et al.  Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes. , 1983, The Journal of clinical investigation.

[5]  S. Peters,et al.  Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. , 1983, The Journal of clinical investigation.

[6]  B. Samuelsson Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.

[7]  R. Bergland,et al.  Dynamics of cortisol and endorphin responses to graded doses of synthetic ovine CRF in sheep. , 1983, Endocrinology.

[8]  Z. Kovačević,et al.  Mitochondrial metabolism of glutamine and glutamate and its physiological significance. , 1983, Physiological reviews.

[9]  T. Miyata,et al.  Cloning and sequence analysis of cDNA for ovine corticotropin-releasing factor precursor , 1983, Nature.

[10]  S. Snyder,et al.  Multiple serotonin receptors and their physiological significance. , 1983, Federation proceedings.

[11]  G. Gillies,et al.  Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin , 1982, Nature.

[12]  J. Funder,et al.  Mineralocorticoid and glucocorticoid effects on 31,000- and 29,000-dalton proopiomelanocortin in rat anterior pituitary and neurointermediate lobe. , 1982, The Journal of clinical investigation.

[13]  F. Bloom,et al.  beta-Endorphin enhances lymphocyte proliferative responses. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Jolles,et al.  Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects. , 1982, Physiological reviews.

[15]  N. Elshourbagy,et al.  Immunochemical evidence for induction of a common form of hepatic cytochrome P-450 in rats treated with pregnenolone-16 alpha-carbonitrile or other steroidal or non-steroidal agents. , 1982, Molecular pharmacology.

[16]  T. Gelehrter,et al.  The dexamethasone-induced inhibitor of fibrinolytic activity in hepatoma cells. A cellular product which specifically inhibits plasminogen activation. , 1982, The Journal of biological chemistry.

[17]  M. Greer,et al.  Corticotropin-releasing factor. , 1982, Endocrine reviews.

[18]  I. Mazurkiewicz-Kwilecki,et al.  Effect of diphenhydramine on stress-induced changes in brain histidine decarboxylase activity, histamine and plasma corticosterone levels , 1982, Pharmacology Biochemistry and Behavior.

[19]  J. Hamilton Stimulation of the plasminogen activator activity of human synovial fibroblasts by retinoids. , 1982, Arthritis and rheumatism.

[20]  R. Palmiter,et al.  Glucocorticoid regulation of the mouse metallothionein I gene is selectively lost following amplification of the gene. , 1982, The Journal of biological chemistry.

[21]  S. Maier,et al.  Corticosterone: a critical factor in an opioid form of stress-induced analgesia. , 1982, Science.

[22]  G. Hartmann,et al.  Enhancement of stress-induced analgesia in adrenalectomized mice: Its reversal by dexamethasone , 1982, Pharmacology Biochemistry and Behavior.

[23]  L. Marnett,et al.  Cytochrome P-450-dependent oxygenation of arachidonic acid to hydroxyicosatetraenoic acids. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[24]  F E Bloom,et al.  Behavioral effects of neuropeptides: endorphins and vasopressin. , 1982, Annual review of physiology.

[25]  V. Paetkau Lymphokines on the move , 1981, Nature.

[26]  A. Munck,et al.  T cell growth factor receptors. Quantitation, specificity, and biological relevance , 1981, The Journal of experimental medicine.

[27]  W. Vale,et al.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin , 1981 .

[28]  P. Black,et al.  Dexamethasone inhibition and phorbol myristate acetate stimulation of plasminogen activator in human embryonic lung cells. , 1981, Biochemical and biophysical research communications.

[29]  W. Bunney,et al.  SURGICAL STRESS AND ENDORPHINS , 1981, The Lancet.

[30]  N. Holbrook,et al.  Glucocorticoid receptor properties and glucocorticoid regulation of glutamine synthetase activity in sensitive C6 and resistant C6H glial cells , 1981, Journal of neuroscience research.

[31]  I. Mellman,et al.  Structural Aspects and Heterogeneity of Immunoglobulin Fc Receptors. , 1981, Advances in immunology.

[32]  E. Sorkin,et al.  Lymphokine-containing supernatants from con A-stimulated cells increase corticosterone blood levels. , 1981, Journal of immunology.

[33]  N. Kalin,et al.  Mood and behavioral effects of physostigmine on humans are accompanied by elevations in plasma beta-endorphin and cortisol. , 1980, Science.

[34]  E. Merler,et al.  The effect of Fc fragments of IgG on human mononuclear cell responses. , 1980, Cellular immunology.

[35]  J. Liebeskind,et al.  Opioid and nonopioid mechanisms of stress analgesia. , 1980, Science.

[36]  G. Crabtree,et al.  Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. , 1979, Journal of immunology.

[37]  R. Simantov Glucocorticoids inhibit endorphin synthesis by pituitary cells , 1979, Nature.

[38]  J. Fouts,et al.  Precocious development of cytochrome P-450 in neonatal rat liver after glucocorticoid treatment. , 1979, The Biochemical journal.

[39]  Schmidt Tj,et al.  Glucocorticoid receptors and glutamine synthetase in leukemic Sézary cells. , 1979 .

[40]  N Eigler,et al.  Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia. , 1979, The Journal of clinical investigation.

[41]  Lefer Am Properties of cardioinhibitory factors produced in shock. , 1978 .

[42]  R. Guillemin,et al.  Effects of purified hypothalamic corticotropin-releasing factor and other substances on the secretion of adrenocorticotropin and beta-endorphin-like immunoactivities in vitro. , 1978, Endocrinology.

[43]  Z. Werb Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions , 1978, The Journal of experimental medicine.

[44]  G. Barsh,et al.  Dexamethasone modulates binding and action of epidermal growth factor in serum-free cell culture. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[45]  C. Craddock Corticosteroid-induced lymphopenia, immunosuppression, and body defense. , 1978, Annals of internal medicine.

[46]  F. Bloom,et al.  beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. , 1977, Science.

[47]  J. Fahey,et al.  Hydrocortisone inhibition of the bradykinin activation of human synovial fibroblasts. , 1977, Prostaglandins.

[48]  H. Besedovsky,et al.  Network of immune-neuroendocrine interactions. , 1977, Clinical and experimental immunology.

[49]  J. Vassalli,et al.  Macrophage plasminogen activator: Modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides , 1976, Cell.

[50]  A. Kang,et al.  Collagen-and collagen peptide-induced chemotaxis of human blood monocytes , 1976, The Journal of experimental medicine.

[51]  M. Keller,et al.  Changes in Blood Hormone Levels during the Immune Response , 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[52]  M. Wigler,et al.  Glucocorticoid inhibition of the fibrinolytic activity of tumor cells , 1975 .

[53]  A. Eisen,et al.  Regulation of human skin collagenase activity by hydrocortisone and dexamethasone in organ culture. , 1974, Biochemical and biophysical research communications.

[54]  T. M. Glenn Steroids and Shock , 1974 .

[55]  V. Stecher,et al.  The chemotactic activity of fibrin lysis products. , 1972, International archives of allergy and applied immunology.

[56]  A. Munck Glucocorticoid Inhibition of Glucose Uptake by Peripheral Tissues: Old and New Evidence, Molecular Mechanisms, and Physiological Significance , 2015, Perspectives in biology and medicine.

[57]  G. Curzon Effects of adrenal hormones and stress on brain serotonin. , 1971, The American journal of clinical nutrition.

[58]  A. R. Green,et al.  Decrease of 5-Hydroxytryptamine in the Brain provoked by Hydrocortisone and its Prevention by Allopurinol , 1968, Nature.

[59]  B. Schaumburg,et al.  Specificity and thermodynamic properties of the corticosteroid binding to a receptor of rat thymocytes in vitro. , 1968, Biochimica et biophysica acta.

[60]  M. Weil,et al.  Corticosteroids for reversal of hemorrhagic shock in rats. , 1965, American Journal of Physiology.

[61]  T. Miya,et al.  ENDOCRINE MODIFICATION OF DRUG RESPONSES IN THE RAT. , 1965, The Journal of pharmacology and experimental therapeutics.

[62]  M. Weil,et al.  Pressor responses to norepinephrine in humans before and after corticosteroids. , 1962, The American journal of physiology.

[63]  I E BUSH,et al.  Chemical and biological factors in the activity of adrenocortical steroids. , 1962, Pharmacological reviews.

[64]  L. Goldstein,et al.  The effect of hydrocortisone on tyrosine-alpha-ketoglutarate transaminase and tryptophan pyrrolase activities in the isolated, perfused rat liver. , 1962, The Journal of biological chemistry.

[65]  D. Ingle,et al.  THE RELATIONSHIP OF THE ADRENAL GLANDS TO DISEASES OF ADAPTATION , 1960 .

[66]  M. Goldstein,et al.  The adrenal cortex and the sympathetic nervous system. , 1957, Physiological reviews.

[67]  H SELYE,et al.  [General adaptation syndrome and diseases of adaptation]. , 1946, L'union medicale du Canada.

[68]  G. Sayers THE ADRENAL CORTEX AND HOMEOSTASIS , 1950 .

[69]  P. Hench,et al.  The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. , 1949, Proceedings of the staff meetings. Mayo Clinic.